Centessa Pharmaceuticals earnings were -$223.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CNTA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$26.1M, down 76.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNTA reported annual earnings of -$235.8M, with 56% growth.
Centessa Pharmaceuticals Earnings Reports & History FAQ
What were Centessa Pharmaceuticals's earnings last quarter?
Centessa Pharmaceuticals (NASDAQ: CNTA) reported Q1 2025 earnings per share (EPS) of -$0.20, up 47.37% year over year. Total CNTA earnings for the quarter were -$26.14 million. In the same quarter last year, Centessa Pharmaceuticals's earnings per share (EPS) was -$0.38.
Is Centessa Pharmaceuticals profitable or losing money?
As of the last Centessa Pharmaceuticals earnings report, Centessa Pharmaceuticals is currently losing money. Centessa Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$223.85 million, a 61.72% increase year over year.
What was CNTA's earnings growth in the past year?
As of Centessa Pharmaceuticals's earnings date in Q2 2025, Centessa Pharmaceuticals's earnings has grown year over year. CNTA earnings in the past year totalled -$223.85 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.